Sirio Pharma Co.,Ltd.’s Net Profit Dropped 27.3% in First Half of 2023

Sirio Pharma Co.,Ltd. (仙乐健康科技股份有限公司) (300791.SZ) reported a net profit of 79.9 million yuan in the first half of 2023, down 27.3% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, up 39% year-on-year.

At the end of the reporting period, it had 4.8 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 38.9%.